BMRN

#695
BioMarin Pharmaceuticals Inc
61.73
+2.30%
Settore:
Base:
Valuta di Profitto:
Intervallo Giornaliero
61.73
61.73
Intervallo Annuale
50.76
73.51
Variazione giornaliera
+2.30%
Variazione Mensile
+8.81%
Variazione di 6 mesi
+5.58%
Variazione Annuale
-10.69%
Chiusura Precedente
60.34
Open
61.73
Bid
Ask
Low
61.73
High
61.73
Volume
168
Open full chart

Financials

Overview Estratto Conto Statistics Dividends
Quarterly Annual
Income statement Balance sheet Cash flow
Value 202020212022202320242025 TTM

BioMarin Pharmaceutical Inc

BioMarin Pharmaceutical Inc. is an American biotechnology company headquartered in San Rafael, California. It has offices and facilities in the United States, South America, Asia, and Europe. BioMarin's core business and research are in enzyme replacement therapies. BioMarin was the first company to provide therapeutics for mucopolysaccharidosis type I, by manufacturing laronidase. BioMarin was also the first company to provide therapeutics for phenylketonuria. Over the years, BioMarin has been criticised for drug pricing and for specific instances of denying access to drugs in clinical trials.

Notizie